vimarsana.com

அலிஸா வாடேநாப்ய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CureMetrix Receives 2nd Approval in Brazil from ANVISA for cmAssist AI-Based Software for Mammography

CureMetrix cmAssist by CureMetrix helps radiologists by identifying, marking and scoring regions of interest on screening mammograms Improving sensitivity and specificity, cmAssist AI-CAD acts as a ‘second pair of eyes’ for the radiologist, delivering efficiency and more accurate detection of breast cancer for the women of Brazil.” Alyssa Watanabe, MD, FACR, Chief Medical Officer CureMetrix SAN DIEGO, CA, USA, May 12, 2021 /EINPresswire.com/ CureMetrix, Inc., a global healthcare technology company that develops AI-driven software for radiology, announced it has received approval from Brazil’s Agência Nacional de Vigilância Sanitária (ANVISA) for cmAssist ®, its proprietary AI-based detection software for mammography. This ANVISA registration 81464750084 allows CureMetrix to market cmAssist to radiology practices and hospitals in Brazil.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.